Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Dabigatrana^i2^s"'
Autor:
Cleidson Alves Bergami, Isabela Laudares Marques, Claudia Oliveira Dias Passos, Felipe Dias Leal, Isabela Azevedo Mota, Zilda de Santana Gonsalves, Marcelo Kropf, Marcele Lima Monte Gonçalves
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Volume: 47, Issue: 4, Pages: 655-663, Published: DEC 2011
Brazilian Journal of Pharmaceutical Sciences, Vol 47, Iss 4, Pp 655-663 (2011)
Brazilian Journal of Pharmaceutical Sciences; Vol. 47 No. 4 (2011); 655-663
Brazilian Journal of Pharmaceutical Sciences; Vol. 47 Núm. 4 (2011); 655-663
Brazilian Journal of Pharmaceutical Sciences; v. 47 n. 4 (2011); 655-663
Brazilian Journal of Pharmaceutical Sciences
Universidade de São Paulo (USP)
instacron:USP
Brazilian Journal of Pharmaceutical Sciences, Vol 47, Iss 4, Pp 655-663 (2011)
Brazilian Journal of Pharmaceutical Sciences; Vol. 47 No. 4 (2011); 655-663
Brazilian Journal of Pharmaceutical Sciences; Vol. 47 Núm. 4 (2011); 655-663
Brazilian Journal of Pharmaceutical Sciences; v. 47 n. 4 (2011); 655-663
Brazilian Journal of Pharmaceutical Sciences
Universidade de São Paulo (USP)
instacron:USP
Anticoagulant therapy is essential for the prevention of risks associated with the formation of thrombus in patients after surgery, especially in orthopedics. Recently, new oral anticoagulants were introduced in the therapeutic arsenal. This fact is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d933f42ead57193be718baef3338c716
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502011000400002&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502011000400002&lng=en&tlng=en